THERAPEUTIC ANDROGEN Gene Set
Genes
17 interacting proteins for the THERAPEUTIC ANDROGEN drug from theDGIdb Drug Targets 2026 dataset.
| Symbol |
Name |
Standardized Value |
|
GADD45G
|
growth arrest and DNA-damage-inducible, gamma
|
6.22729
|
|
CD52
|
CD52 molecule
|
1.55682
|
|
CD9
|
CD9 molecule
|
0.691921
|
|
AQP9
|
aquaporin 9
|
0.622729
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
0.444807
|
|
TAT
|
tyrosine aminotransferase
|
0.415153
|
|
FST
|
follistatin
|
0.415153
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
0.327752
|
|
IGF2
|
insulin-like growth factor 2
|
0.311365
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
0.23064
|
|
TAC1
|
tachykinin, precursor 1
|
0.222403
|
|
PTH
|
parathyroid hormone
|
0.163876
|
|
TGFB1
|
transforming growth factor, beta 1
|
0.105547
|
|
GSTP1
|
glutathione S-transferase pi 1
|
0.105547
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
0.0622729
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
0.0372892
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
0.0127608
|